# Ginkgo Biloba Prevention Trial in Older Individuals

Clinical trial · National Center for Complementary and Integrative Health (NCCIH)

- Archive id: nct:NCT00010803
- Published: 2001-02-05
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT00010803
- Source URL: https://clinicaltrials.gov/study/NCT00010803
- Provenance: clinicaltrials

## Abstract

This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional disability, reducing incidence of cardiovascular disease, and decreasing total mortality.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- status: COMPLETED
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 3069
- sponsor: National Center for Complementary and Integrative Health (NCCIH)
- conditions: Dementia; Alzheimer's Disease
- interventions: DRUG: Ginkgo biloba; DRUG: Placebo
- start date: 2000-10-01
- primary completion date: 2008-04-01
- has results: true
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.